Curanex Pharmaceuticals Inc (CURX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CURX Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Curanex Pharmaceuticals Inc's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent2.94
Cash & Short-term Investments2.00
Other Current Assets0.00
Prepaid Expense, Current AS1.85
Total Current Assets4.79
Tax Assets, Noncurrent2.37
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset0.32
Total Assets5.07
Liabilities
Accounts Payable, Current AC0.00
Accrued Liabilities, Current AC0.01
Other Liabilities, Current0.09
Total Current Liabilities0.10
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.18
Operating Lease Liability Current0.11
Operating Lease Liability Noncurrent0.20
Total Liabilities0.29
Stockholders' Equity
Common Stock To Be Issued-
Common Stock Value0.00
Additional Paid In Capital Common Stock16.07
Retained Earnings / Accumulated Deficit-11.29
Other Equity0.00
Common Stockholder's Equity4.79
Preferred Stockholder's Equity0.00
Total Stockholder's Equity4.79
Liabilities & Stockholder's Equity5.07
4 historic quarters locked

Sign in to unlock the full Curanex Pharmaceuticals Inc balance sheet history.

About Curanex Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 14, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-038145

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.